Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
接受芬戈莫德、那他珠单抗、利妥昔单抗和注射疗法治疗的多发性硬化症患者的感染风险
期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2019.3365
Luna, Gustavo; Alping, Peter; Burman, Joachim; Fink, Katharina; Fogdell-Hahn, Anna; Gunnarsson, Martin; Hillert, Jan; Langer-Gould, Annette; Lycke, Jan; Nilsson, Petra; Salzer, Jonatan; Svenningsson, Anders; Vrethem, Magnus; Olsson, Tomas; Piehl, Fredrik; Frisell, Thomas